Mérieux Equity Partners SAS

PE/Buy-Out · Lyon (France)

PE/Buy-Out

Seed

Series A

Healthcare

Sign up free to access full profile and submit your pitch.

About

Mérieux Equity Partners is a leading European healthcare-specialized investment firm managing over €1.6bn. It operates through two platforms: Innovation (Seed to Series B) and Buyout (growth and profitable companies).

Investment Criteria

Other investors that have backed the same portfolio companies as Mérieux Equity Partners SAS. Expand any entry to see the shared portfolio companies.

• Korys

  14 shared

  Shared portfolio companies

  • AcuSurgical SAS
  • Amyl Therapeutics SRL
  • AstriVax NV
  • Broken String Biosciences Ltd.
  • Cairdac
  • Cell-Easy SAS
  • CorFlow Therapeutics AG
  • MIMETAS B.V.
  • MRM Health NV
  • MRM Technologies N.V.
  • ProDigest
  • Prothea Technologies Ltd.
  • SeqOne S.A.S.
  • Triple Ring Technologies, Inc.
• Supernova Invest

  4 shared

  Shared portfolio companies

  • AcuSurgical SAS
  • Cairdac
  • Keranova S.A.
  • SeqOne S.A.S.
• Irdi Soridec Gestion

  3 shared

  Shared portfolio companies

  • AcuSurgical SAS
  • Cell-Easy SAS
  • SeqOne S.A.S.
• Ardian Growth

  2 shared

  Shared portfolio companies

  • Ceva Sante Animale
  • Groupe ELSAN SAS
• BNP Paribas Fortis Private Equity Expansion NV

  2 shared

  Shared portfolio companies

  • AstriVax NV
  • MRM Health NV
• Gemma Frisius Fund

  2 shared

  Shared portfolio companies

  • AstriVax NV
  • MRM Health NV
• Omnes Capital

  2 shared

  Shared portfolio companies

  • SeqOne S.A.S.
  • TISSIUM S.A.
• Panakes

  2 shared

  Shared portfolio companies

  • CorFlow Therapeutics AG
  • Deepull Diagnostics, S.L.
• UI Investissement, SAS

  2 shared

  Shared portfolio companies

  • AcuSurgical SAS
  • Deepull Diagnostics, S.L.
• 1315 Capital, LLC

  1 shared

  Shared portfolio companies

  • Triple Ring Technologies, Inc.